eISSN: 2377-4304
Submit manuscript...
Short Communication Volume 11 Issue 1
Treatment of chronic pelvic pain
Kramarskiy Vladimir A
Irkutsk state medical Academy of postgraduate education, branch of the Russian medical Academy of continuing professional education, Russia
Received: December 24, 2019 | Published: January 21, 2020
Citation: Kramarskiy VS. Treatment of chronic pelvic pain. Obstet Gynecol Int J. 2020;11(1):11-12. DOI: 10.15406/ogij.2020.11.00482
Abstract
Chronic pelvic pain syndrome (HTB) is one of the problems of modern women. The applied methods of treatment are not always effective due to the multifactorial nature of the causes of the disease. Goal: search for the most optimal therapy aimed at enhancing the processes of sanogenesis, more effective response of the body to pain syndrome. We studied 2 groups of patients with HTB. !1 group of 14 women with HTB were treated by injecting the drug traumel C into the pelvic pain points, and in the second group (32 women), Ketonal was used on novocaine using the same technology. 14 months after treatment, all women in group 1 and 20% of women in the second group had no recedive.
Keywords: Pelvic pain, Treatment, Traumel-C, Chronic pelvic pain syndrome, Abdomen, Gynecological pathology, Women, Accumulation, Mental stress, Hypothermia, Anti-inflammatory drugs, Antibiotics, Painkillers, Combined oral contraceptives, Neuralgia
©2020 Kramarskiy. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.